Evidence map›Paper›PMID 33968808›Full record

ArticleFrontiers in cellular and infection microbiology2021

Could Nutraceutical Approaches Possibly Attenuate the Cytokine Storm in COVID-19 Patients?

Ramachandran Vignesh, Vijayakumar Velu, Sripathi M Sureban

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. [How does COVID-19 affect intestinal microbiota?]MMW Fortschritte der Medizin · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Ramachandran VigneshPreclinical Department, Royal College of Medicine Perak (UniKL RCMP), Universiti Kuala Lumpur, Ipoh, Malaysia.
Vijayakumar VeluDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Division of Microbiology & Immunology, Yerkes National Primate Center, Atlanta, GA, United States.
Sripathi M SurebanDigestive Diseases and Nutrition Section, Department of Internal Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Emory University · USUniversity of Kuala Lumpur · MYUniversity of Oklahoma Health Sciences Center · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Combined cytokine therapy for sustained HIV remissionR01AI148377 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO, VELU, VIJAYAKUMAR · 2020 to 2024
$4.6M
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV riskR01HD095741 · NICHD · EMORY UNIVERSITY · PI HADDAD, LISA BLAKE, SMITH, ALICIA K · 2018 to 2022
$3.8M
NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI148377NICHD NIH HHS R01 HD095741NIH HHS P51 OD011132
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Gastrointestinal MicrobiomeCytokine Release SyndromeDietary SupplementsHumansSARS-CoV-2COVID-19gut microbiotanutraceuticalsPectinprobioticsSARS-CoV-2

Identifiers

PMID33968808
PMCPMC8102864
OpenAlexW3159146332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.